BioVie Inc (NAS:BIVI)
$ 2.8 0.09 (3.32%) Market Cap: 49.75 Mil Enterprise Value: 33.44 Mil PE Ratio: 0 PB Ratio: 1.58 GF Score: 31/100

BioVie Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 15, 2023 / 04:40PM GMT
Release Date Price: $98.3 (+6.85%)
Jay Olson
Oppenheimer & Co. Inc. - Analyst

Hello, everyone, and welcome to Oppenheimer's 33rd annual healthcare conference. I'm Jay Olson, one of the biotech analysts at Oppenheimer. And I want to thank you all for joining us here today.

It's a pleasure to welcome BioVie to our conference, and it's an honor to introduce Cuong Do, the CEO. Thank you so much for joining us today, Cuong.

Cuong Do
BioVie Inc. - President & CEO

Thank you so much for having me with you today.

Jay Olson
Oppenheimer & Co. Inc. - Analyst

Absolutely, our pleasure. It's always great to catch up with you. And I'll turn it over to you for your presentation, and I'll come back at the end, and see if we have any question.

Cuong Do
BioVie Inc. - President & CEO

All right. Terrific. Thank you, everyone, for joining us today. I'll just try spend about 20-25 minutes or so giving you our story, then I'll save some time for Q&A at the end. So, please queue up your questions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot